AI Tool Aims to Match Alzheimer's Patients to the Right Treatment
NeuroXT and BIDMC expand their AI-imaging collaboration to predict which Alzheimer's patients will respond to which therapies.
Biological age reversal, epigenetic clocks, senolytics, and anti-aging interventions
1,795 articles
NeuroXT and BIDMC expand their AI-imaging collaboration to predict which Alzheimer's patients will respond to which therapies.
Chlorogenic acid boosts ATP by up to 80%, clears senescent cells, and rebuilds collagen — potentially redefining topical anti-aging treatment.
Epigenetic clock pioneer Steve Horvath breaks down which everyday interventions measurably shift biological age — and which don't.
New research reveals that both abnormally short and ultra-long telomeres cause distinct inherited diseases, reshaping how we understand aging and cancer risk.
A meta-analysis comparing neurofeedback, tDCS, and TMS for adult ADHD finds encouraging signals but no technique yet reaches statistical significance.
A longevity-linked protein given orally reduces artery-clogging inflammation from fat tissue in obese mice, without requiring weight loss.
A 2026 review maps the emerging chemical toolkit targeting CD38, the enzyme that depletes NAD+ during aging, cancer, and inflammation.
A new review reveals how disrupted HPO axis hormones—not just estrogen loss—drive dementia risk in menopause, POI, and PCOS.
A comprehensive 2025 review links sarcopenia's cellular mechanisms to neurodegeneration and outlines multicomponent treatments that work.
Long-term nucleotide supplementation boosted muscle mass, strength, and fiber size in aging mice by suppressing key protein-degradation genes.
A comprehensive review reveals how tailored exercise programs counter aging's biological hallmarks and prevent frailty across all fitness levels.
Machine learning models tracking 40+ cell types via blood proteins can forecast disease risk years before diagnosis, Stanford research shows.